Paolo Marchetti | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective analysis of progression-free (PFS) and overall survival (OS) in the “Real Life”	ANNALS OF ONCOLOGY	2015
Abiraterone acetate in metastatic castration-resistant prostate cancer after chemotherapy. A retrospective “Real Life” analysis of activity and safety	EUROPEAN JOURNAL OF CANCER	2015
Association between proton-pump inhibitors (PPI) and metronomic capecitabine (MCAP) as salvage treatment for patients with advanced gastro-intestinal tumoursa. A randomized phase II study	EUROPEAN JOURNAL OF CANCER	2015
Italian oncological pain survey (IOPS). a multicentre Italian study of breakthrough pain performed in different settings	THE CLINICAL JOURNAL OF PAIN	2015
Effect of MTHFR polymorphisms on gastrointestinal cancer risk in Italy	WORLD JOURNAL OF ONCOLOGY	2015
Genetic polymorphism can help physician choosing the best lung cancer chemotherapy	ANNALS OF ONCOLOGY	2015
Electrochemotherapy treatment of cutaneous metastases from breast cancer	THE AMERICAN SURGEON	2015
Positive impact of elastography in breast cancer diagnosis: an institutional experience	JOURNAL OF ULTRASOUND	2015
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer	ANTI-CANCER DRUGS	2015
Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group	SUPPORTIVE CARE IN CANCER	2015
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram	THE ONCOLOGIST	2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: Results from a phase I trial in advanced melanoma	JOURNAL OF TRANSLATIONAL MEDICINE	2015
FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?	WORLD JOURNAL OF ONCOLOGY	2015
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure	EXPERT REVIEW OF ANTICANCER THERAPY	2015
Widespread renal polycystosis induced by crizotinib	TUMORI	2015
Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma	CASE REPORTS IN ONCOLOGICAL MEDICINE	2015

« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13